Rotate CJC-1295 & Ipamorelin Injection Sites: Comparison
Once daily (CJC-1295 no DAC alone or ipamorelin once daily) 8 sites Grid Method (abdominal quadrants) or Clockface Method 1 use per 8 days (meets 7-day rest minimum) 7–10 days for full collagen remodeling and capillary regrowth Single daily dosing is the easie
This comparison does not assign a generated winner or score.
- Once daily (CJC-1295 no DAC alone or ipamorelin once daily)
- 8 sites
- Grid Method (abdominal quadrants) or Clockface Method
- 1 use per 8 days (meets 7-day rest minimum)
- 7–10 days for full collagen remodeling and capillary regrowth
- Single daily dosing is the easiest frequency to manage. Eight abdominal sites provide sufficient rotation without needing thigh or arm zones
- Twice daily (ipamorelin AM + PM, CJC-1295 weekly)
- 12–14 sites
- Grid Method with thigh integration, or Zone Blocking (abdomen AM, thighs PM)
- 2 uses per 7 days (minimum acceptable with expanded site pool)
- Same 7–10 days, but higher injection frequency accelerates cumulative micro-trauma if spacing is insufficient
- Twice-daily protocols require disciplined tracking. Use a physical chart or app to mark every injection site, as mental tracking fails by week 3
- Three times daily (aggressive ipamorelin protocols)
- 16+ sites
- Grid Method across abdomen + thighs + arms, strict tracking required
- 2–3 uses per 7 days (acceptable only with 16+ site rotation)
- 10–14 days recommended due to higher cumulative tissue stress
- Three-times-daily frequency is where most researchers encounter tissue fatigue issues. Consider reducing frequency or integrating oral alternatives if viable for research goals
- Weekly only (CJC-1295 no DAC without daily ipamorelin)
- 4 sites minimum, 8 recommended
- Simple alternating quadrants (lower left, lower right, upper left, upper right)
- 1 use per 28 days (ample recovery time)
- Minimal tissue stress. Standard 7-day recovery easily maintained
- Weekly-only protocols allow for the most conservative rotation. Even four sites provide a full month between re-use, virtually eliminating lipohypertrophy risk